West Pharmaceutical Services ROE 2010-2023 | WST

Current and historical return on equity (ROE) values for West Pharmaceutical Services (WST) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
West Pharmaceutical Services ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $0.59B $2.88B 21.04%
2023-09-30 $0.56B $2.87B 20.19%
2023-06-30 $0.52B $2.75B 19.44%
2023-03-31 $0.55B $2.78B 21.36%
2022-12-31 $0.59B $2.69B 23.70%
2022-09-30 $0.63B $2.47B 26.45%
2022-06-30 $0.69B $2.42B 29.59%
2022-03-31 $0.69B $2.33B 30.80%
2021-12-31 $0.66B $2.34B 31.53%
2021-09-30 $0.61B $2.20B 30.91%
2021-06-30 $0.52B $2.03B 27.86%
2021-03-31 $0.42B $1.83B 24.08%
2020-12-31 $0.35B $1.86B 20.69%
2020-09-30 $0.31B $1.72B 19.47%
2020-06-30 $0.29B $1.61B 18.52%
2020-03-31 $0.26B $1.49B 17.34%
2019-12-31 $0.24B $1.57B 16.41%
2019-09-30 $0.23B $1.49B 16.07%
2019-06-30 $0.23B $1.45B 16.39%
2019-03-31 $0.22B $1.37B 16.15%
2018-12-31 $0.21B $1.40B 15.52%
2018-09-30 $0.16B $1.35B 11.88%
2018-06-30 $0.15B $1.28B 11.65%
2018-03-31 $0.13B $1.31B 10.42%
2017-12-31 $0.15B $1.28B 12.06%
2017-09-30 $0.19B $1.32B 15.68%
2017-06-30 $0.18B $1.24B 15.16%
2017-03-31 $0.18B $1.17B 16.13%
2016-12-31 $0.14B $1.12B 12.96%
2016-09-30 $0.14B $1.14B 12.69%
2016-06-30 $0.10B $1.11B 9.71%
2016-03-31 $0.09B $1.07B 8.33%
2015-12-31 $0.10B $1.02B 9.72%
2015-09-30 $0.09B $1.00B 9.69%
2015-06-30 $0.12B $0.99B 12.76%
2015-03-31 $0.13B $0.94B 13.85%
2014-12-31 $0.13B $0.96B 13.25%
2014-09-30 $0.12B $0.97B 12.68%
2014-06-30 $0.12B $0.97B 12.71%
2014-03-31 $0.11B $0.94B 12.48%
2013-12-31 $0.11B $0.91B 13.81%
2013-09-30 $0.11B $0.84B 14.21%
2013-06-30 $0.10B $0.78B 13.17%
2013-03-31 $0.08B $0.75B 11.70%
2012-12-31 $0.08B $0.73B 11.49%
2012-09-30 $0.08B $0.72B 11.50%
2012-06-30 $0.08B $0.68B 11.91%
2012-03-31 $0.09B $0.70B 12.42%
2011-12-31 $0.08B $0.66B 11.24%
2011-09-30 $0.06B $0.69B 9.42%
2011-06-30 $0.06B $0.70B 9.78%
2011-03-31 $0.07B $0.66B 10.59%
2010-12-31 $0.07B $0.63B 10.96%
2010-09-30 $0.08B $0.63B 13.55%
2010-06-30 $0.08B $0.57B 13.76%
2010-03-31 $0.08B $0.58B 13.64%
2009-12-31 $0.07B $0.58B 13.29%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $27.235B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
Becton Dickinson (BDX) United States $67.638B 19.64
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00